Media Summary: This presentation explained the role and function of the Division of Industry and Consumer Education (DICE) within the This presentation provided an overview of CDRH's Medical Device Development Tools (MDDT) Program and explained what ... This presentation explored medical device coverage initiatives and the role of the Payor Communication Task Force in connecting ...
Fda Nih 2024 D1s14 How - Detailed Analysis & Overview
This presentation explained the role and function of the Division of Industry and Consumer Education (DICE) within the This presentation provided an overview of CDRH's Medical Device Development Tools (MDDT) Program and explained what ... This presentation explored medical device coverage initiatives and the role of the Payor Communication Task Force in connecting ... This presentation provided comprehensive guidance on CDER's nonclinical resources for approaching First-in-Human (FIH) ... This presentation outlined CDER's clinical considerations for First-in-Human trials and presented general good practices for FIH ... This presentation provided information about the Small Business and Industry Assistance (SBIA) and its mission. Topics ...
This presentation introduced CBER's Manufacturers Assistance and Technical Training Branch (MATTB) and explained their ... This presentation provided information on the National Cancer Institute's Small Business Innovation Research (SBIR) ... This presentation explored the essential components of Chemistry, Manufacturing, and Controls (CMC) within pharmaceutical ... This presentation discussed a rundown of the Do's and Don'ts from The first of three Q&A discussion panels from the This presentation provided guidance on nonclinical assessment of Cell and Gene Therapy (CGT) products to support IND ...
This presentation highlighted key clinical regulatory issues encountered during early-phase development of cellular and gene ... The last of three Q&A discussion panels from the This inaugural webinar was a collaborative effort between The second of three Q&A discussion panels from the This presentation explored regulatory resources and avenues for obtaining early guidance from CBER's Office of Therapeutic ... This presentation addressed CBER's Chemistry, Manufacturing, and Control considerations for early phase studies of cell and ...
